 | |
| Clinical data | |
|---|---|
| Other names | 14β-Hydroxy-3β-[α-L-rhamnopyranosyl)oxy]bufa-4,20,22-trienolide |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.006.702 |
| Chemical and physical data | |
| Formula | C30H42O8 |
| Molar mass | 530.658 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Proscillaridin is acardiac glycoside, a kind of drug that can be used in the treatment ofcongestive heart failure andcardiac arrhythmia (irregular heartbeat). It is of thebufanolide type and can be obtained from plants of the genusScilla and inDrimia maritima (Scilla maritima).[1]
Theaglycone of proscillaridin isscillarenin.
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |